CRISPR, MassGen using CRISPR to improve T cell therapies

CRISPR Therapeutics AG (NASDAQ:CRSP) and Massachusetts General Hospital (Boston, Mass.) partnered to use CRISPR-Cas9 (CRISPR-associated protein 9) to improve on current T cell therapies in developme...